Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts $16.40 -0.42 (-2.50%) (As of 07/5/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateJul. 31Before Market OpensConfirmedActual EPS (May. 8) $0.46 Missed By -$0.03 Consensus EPS (May. 8) $0.49 Get Teva Pharmaceutical Industries Earnings AlertsEnter your email address below to receive the latest news and earnings results for TEVA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTEVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TEVA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Teva Pharmaceutical Industries Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.48$0.48$0.48 Q2 20241$0.56$0.56$0.56 Q3 20241$0.57$0.57$0.57 Q4 20241$0.68$0.68$0.68 FY 20244$2.29$2.29$2.29 Q1 20251$0.44$0.44$0.44 Q2 20251$0.57$0.57$0.57 Q3 20251$0.64$0.64$0.64 Q4 20251$0.83$0.83$0.83 FY 20254$2.48$2.48$2.48 Q1 20261$0.50$0.50$0.50 TEVA Earnings Date and InformationTeva Pharmaceutical Industries last posted its quarterly earnings results on May 8th, 2024. The reported $0.46 EPS for the quarter, missing analysts' consensus estimates of $0.49 by $0.03. The company had revenue of $3.82 billion for the quarter, compared to the consensus estimate of $3.70 billion. Teva Pharmaceutical Industries has generated ($0.41) earnings per share over the last year (($0.41) diluted earnings per share). Earnings for Teva Pharmaceutical Industries are expected to grow by 12.93% in the coming year, from $2.32 to $2.62 per share. Teva Pharmaceutical Industries has confirmed that its next quarterly earnings report will be published on Wednesday, July 31st, 2024. Teva Pharmaceutical Industries will be holding an earnings conference call on Wednesday, July 31st at 8:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Teva Pharmaceutical Industries Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/31/2024(Confirmed)------- 5/8/2024Q1 2024$0.49$0.46($0.03)$1.04$3.70 billion$3.82 billion1/31/2024Q4 2023$0.73$0.98+$0.25$1.55$3.97 billion$4.46 billion11/8/2023Q3 2023$0.57$0.60+$0.03$1.09$3.73 billion$3.90 billion 8/2/2023Q2 2023$0.52$0.54+$0.02$1.85$3.69 billion$3.88 billion5/10/2023Q1 2023$0.55$0.37($0.18)$0.92$3.60 billion$3.66 billion2/8/2023Q4 2022$0.64$0.68+$0.04$2.46$3.90 billion$3.88 billion Get the Latest News and Ratings for TEVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022$0.58$0.56($0.02)$1.07$3.86 billion$3.60 billion 7/26/2022Q2 2022$0.55$0.64+$0.09$1.49$3.82 billion$3.79 billion5/3/2022Q1 2022$0.53$0.53-$1.92$3.75 billion$3.66 billion 2/9/2022Q4 2021$0.70$0.74+$0.04$1.62$4.28 billion$4.10 billion 10/27/2021Q3 2021$0.65$0.59($0.06)$0.88$4.05 billion$3.89 billion 7/28/2021Q2 2021$0.55$0.59+$0.04$0.95$4.03 billion$3.91 billion 4/28/2021Q1 2021$0.55$0.63+$0.08$1.13$4.04 billion$3.98 billion 2/10/2021Q4 2020$0.63$0.68+$0.05$1.14$4.37 billion$4.45 billion 11/5/2020Q3 2020$0.58$0.58-$5.09$4.09 billion$4.00 billion 8/5/2020Q2 2020$0.53$0.55+$0.02$0.91$3.94 billion$3.87 billion 5/7/2020Q1 2020$0.59$0.76+$0.17$1.40$4.15 billion$4.36 billion 2/12/2020Q4 2019$0.61$0.62+$0.01$1.12$4.35 billion$4.47 billion 11/7/2019Q3 2019$0.58$0.56($0.02)$1.41$4.25 billion$4.26 billion 8/7/2019Q2 2019$0.55$0.57+$0.02$1.77$4.25 billion$4.34 billion Teva Pharmaceutical Industries Earnings - Frequently Asked Questions When is Teva Pharmaceutical Industries's earnings date? Teva Pharmaceutical Industries has confirmed that its next quarterly earnings data will be published on Wednesday, July 31st, 2024. Learn more on TEVA's earnings history. What guidance has Teva Pharmaceutical Industries issued on next quarter's earnings? Teva Pharmaceutical Industries issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of 2.200-2.500 for the period, compared to the consensus estimate of 2.410. The company issued revenue guidance of $15.7 billion-$16.3 billion, compared to the consensus revenue estimate of $15.9 billion. Did Teva Pharmaceutical Industries beat their earnings estimates last quarter? In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) missed the analysts' consensus estimate of $0.49 by $0.03 with a reported earnings per share (EPS) of $0.46. Learn more on analysts' earnings estimate vs. TEVA's actual earnings. How much revenue does Teva Pharmaceutical Industries generate each year? Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.85 billion. How much profit does Teva Pharmaceutical Industries generate each year? Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$559 million. TEVA has generated -$0.41 earnings per share over the last four quarters. What is Teva Pharmaceutical Industries's price-to-earnings ratio? Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 7.07. The price/earnings-to-growth ratio is 1.55. What is Teva Pharmaceutical Industries's EPS forecast for next year? Teva Pharmaceutical Industries's earnings are expected to grow from $2.32 per share to $2.62 per share in the next year, which is a 12.93% increase. More Earnings Resources from MarketBeat Related Companies: TAK Earnings Results ALNY Earnings Results GMAB Earnings Results BMRN Earnings Results RPRX Earnings Results BGNE Earnings Results SRPT Earnings Results UTHR Earnings Results VTRS Earnings Results RDY Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Analysts and Earnings Propel the S&P 500's Continuous GrowthBlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings Drop This page (NYSE:TEVA) was last updated on 7/7/2024 by MarketBeat.com Staff From Our Partners270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.